Profil Financier
Zhao Tao occupe actuellement le rang #2211 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.9 B (-$492 sur 24h).
Zhao Tao is the chairman of Shandong Buchang Pharmaceuticals, a supplier of traditional Chinese medicine to fight cardiovascular disease.
Zhao received an MBA from Fordham University in New York City.
Buchang started trading on the Shanghai Stock Exchange in November 2016.
Zhao holds a Singapore passport.